953758-67-3Relevant academic research and scientific papers
Tetrazole-biarylpyrazole derivatives as cannabinoid CB1 receptor antagonists
Kang, Suk Youn,Lee, Sung-Han,Seo, Hee Jeong,Jung, Myung Eun,Ahn, Kwangwoo,Kim, Jeongmin,Lee, Jinhwa
, p. 2385 - 2389 (2008/09/20)
Cannabinoid CB1 receptors have been the focus of extensive studies since the first clinical results of rimonabant (SR141716) for the treatment of obesity and related metabolic disorders were reported in 2001. To further evaluate the properties of CB recep
